CC

Commodore Capital Portfolio holdings

AUM $1.42B
1-Year Est. Return 73.3%
This Quarter Est. Return
1 Year Est. Return
+73.3%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$664M
AUM Growth
+$41.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
41
New
Increased
Reduced
Closed

Top Buys

1
+$27.2M
2
+$20.4M
3
+$18.3M
4
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$14M
5
FDMT icon
4D Molecular Therapeutics
FDMT
+$13.3M

Top Sells

1
+$43.3M
2
+$22.3M
3
+$20.7M
4
VRDN icon
Viridian Therapeutics
VRDN
+$19.8M
5
AKRO icon
Akero Therapeutics
AKRO
+$11.3M

Sector Composition

1 Healthcare 100%
2 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$65.4M 9.86%
1,659,111
+64,179
2
$59M 8.89%
2,020,166
-676,174
3
$49.9M 7.53%
4,319,940
4
$43.6M 6.57%
5,303,557
+175,000
5
$42.3M 6.37%
2,732,567
+116,805
6
$36M 5.42%
5,738,500
7
$29.6M 4.46%
1,880,286
-530,336
8
$29.4M 4.44%
537,076
-206,396
9
$27.2M 4.1%
+913,621
10
$22.1M 3.33%
495,823
-42,989
11
$20.4M 3.08%
+1,150,505
12
$18.7M 2.82%
462,111
+58,033
13
$18.6M 2.8%
1,327,952
+407,488
14
$18.3M 2.76%
+591,437
15
$17.5M 2.64%
688,445
-49,665
16
$15.9M 2.4%
739,661
17
$14M 2.11%
+127,156
18
$13.8M 2.09%
1,643,500
19
$13.6M 2.06%
1,099,407
+200,000
20
$13.3M 2%
+598,385
21
$13.1M 1.98%
+590,705
22
$10.4M 1.57%
223,494
+120,000
23
$10.2M 1.54%
+623,699
24
$9.74M 1.47%
1,325,000
25
$9.65M 1.45%
+758,244
1
2